awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q35642790-07F1B5AD-3488-474C-A4E4-66FDDBF8A695
Q35642790-07F1B5AD-3488-474C-A4E4-66FDDBF8A695
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35642790-07F1B5AD-3488-474C-A4E4-66FDDBF8A695
Beneficial effects of combining nilotinib and imatinib in preclinical models of BCR-ABL+ leukemias.
P2860
Q35642790-07F1B5AD-3488-474C-A4E4-66FDDBF8A695
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35642790-07F1B5AD-3488-474C-A4E4-66FDDBF8A695
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
77673b56eb889b79daae2b9a23424861d7f35060
P2860
Combined Abl inhibitor therapy for minimizing drug resistance in chronic myeloid leukemia: Src/Abl inhibitors are compatible with imatinib.